Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection

In HIV-1-infected patients, virological failure can occur as a consequence of the mutations that accumulate in the viral genome that allow replication to continue in the presence of antiretrovirals (ARVs). The development of treatment-emergent resistance to an ARV can limit a patient's options...

Descripción completa

Detalles Bibliográficos
Autores principales: Boffito, Marta, Waters, Laura, Cahn, Pedro, Paredes, Roger, Koteff, Justin, Van Wyk, Jean, Vincent, Tia, Demarest, James, Adkison, Kimberly, Quercia, Romina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944139/
https://www.ncbi.nlm.nih.gov/pubmed/31507204
http://dx.doi.org/10.1089/aid.2019.0171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944139/
https://www.ncbi.nlm.nih.gov/pubmed/31507204
http://dx.doi.org/10.1089/aid.2019.0171

Ejemplares similares